Thomas Henry
Villejuif, 94805, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 104 publications
An N-terminal CDC42 T43I variant reveals the mechanism of pyrin inflammasome activation.
Journal: Science immunology
Published: August 07, 2026
IglF mediates type VI secretion system spike assembly and promotes Francisella virulence.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: May 18, 2026
Radiotherapy quality assurance in the PRO-GLIO trial: results from a dummy run comparing experts across twelve institutions in two Scandinavian countries.
Journal: Clinical and translational radiation oncology
Published: May 03, 2026
Decoding variants of uncertain significance in systemic autoinflammatory diseases.
Journal: Nature reviews. Rheumatology
Published: April 24, 2026
A novel STAT4 gain-of-function variant defines a monogenic form of juvenile-onset systemic lupus erythematosus.
Journal: Annals of the rheumatic diseases
Published: February 21, 2026
Case Report: Proton beam therapy - friend or foe for patients with IDH-mutated WHO grade 2 and 3 gliomas?
Journal: Frontiers in oncology
Published: February 04, 2026
Francisella tularensis virulence relies on a conserved putative catalytic triad within the Type VI secretion system component PdpC.
Journal: FEMS microbes
Published: January 26, 2026
SpeckSeq enables high-throughput functional stratification of MEFV variants in autoinflammatory diseases.
Journal: The Journal of experimental medicine
Published: May 23, 2025
Protons or Photons in Pituitary Neuroendocrine Tumors-That Is Not the Question.
Journal: International journal of particle therapy
Published: March 16, 2025
IRF2 deficiency disrupts pyroptosis, NK cell interferon-γ production and resistance to Francisella.
Journal: EMBO reports
Published: February 25, 2025
(E, E)-farnesol and myristic acid-loaded lipid nanoparticles overcome colistin resistance in Acinetobacter baumannii.
Journal: International journal of pharmaceutics
Published: June 24, 2024
IFN-γ licenses normal and pathogenic ALPK1/TIFA pathway in human monocytes.
Journal: iScience
Published: April 10, 2024
Last Updated: 09/26/2026